Knife River Corporation KNF 深 沪
等待开盘 02-07 09:30:00 美东时间
80.00
+3.760
+4.93%
华盛通- 最 高80.48
- 今 开77.58
- 成交量 125.10万股
- 最 低 77.52
- 昨 收 76.24
- 总市值 45.33亿
- 52周最高 105.23
- 市盈率 静 22.55
- 换手率 2.21%
- 52周最低 58.72
- 委 比 -33.33%
- 总股本 5666.42万
- 历史最高 108.83
- 量 比 1.62
- 振 幅 3.88%
- 历史最低 33.6712
- 每 手 1
- 风险率 10.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Meta 、IBM、拉姆研究、布林克国际等获多家机构上调目标价；微软、特斯拉、ServiceNow、自动数据处理等遭多家下调评级
今日重点评级关注：Piper Sandler：上调Korro Bio评级至"超配"，目标价从11美元升至30美元；Piper Sandler：维持Nurix Therapeutics"超配"评级，目标价从32美元升至35美元
01-30 17:38
Wells Fargo Maintains Equal-Weight on Knife River Holding, Lowers Price Target to $75
Wells Fargo analyst Timna Tanners maintains Knife River Holding (NYSE:KNF) with a Equal-Weight and lowers the price target from $81 to $75.
01-29 22:38
U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio
U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio Jan 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AGNC Investment, Brown & Brown and Korro Bio, on Thursday. HIGHLIGHTS * AGNC Investment Corp AGNC.O :
01-29 15:54
美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
美股大行评级 | 高盛上调谷歌目标价从330美元升至375美元；5家大行集体上调Five Below目标价最高至255美元
今日重点评级关注：HC Wainwright & Co.：维持NioCorp Developments"买入"评级，目标价从9.5美元升至11.25美元；摩根士丹利：维持Chewy"超配"评级，目标价从48美元升至51美元
01-14 11:25
Wells Fargo Downgrades Knife River Holding to Equal-Weight, Raises Price Target to $81
Wells Fargo analyst Timna Tanners downgrades Knife River Holding (NYSE:KNF) from Overweight to Equal-Weight and raises the price target from $75 to $81.
01-13 22:08
Knife River Expands in Texas With Texcrete Acquisition, Adding Ready-Mix Plants and Aggregate Reserves
Knife River Corporation (NYSE:KNF) announced today that it has acquired the assets of Texcrete Operations LLC and TexAgg LLC (collectively "Texcrete"), supporting the company's growth efforts in the Texas Triangle.Based
2025-12-15 19:32
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
2025-12-05 08:35
JP Morgan Initiates Coverage On Knife River Holding with Neutral Rating, Announces Price Target of $83
JP Morgan analyst Adrian Huerta initiates coverage on Knife River Holding (NYSE:KNF) with a Neutral rating and announces Price Target of $83.
2025-12-04 21:55
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
2025-11-07 10:14
